• 1
    Loesche, W.J. and Kazor, C. Microbiology and treatment of halitosis. Periodentol. 2000 28, 256279 (2002).
  • 2
    Suzuki, N., Yoneda, M., Naito, T., Iwamoto, T. and Hirofuji, T. Relationship between halitosis and psychologic status. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 106, 542547 (2008).
  • 3
    Scully, C., El-Maaytah, M. and Porter, S.R. Breath odor: etiophathogenesis, assessment and management. Eur. J. Oral Sci. 105, 287293 (1997).
  • 4
    ADA Council on Scientific Affairs. Oral malodor. J. Am. Dent. Assoc. 134, 209214 (2003).
  • 5
    Willis, C.L., Gibson, G.R., Allison, C., Macfarlane, S. and Holt, J.S. Growth, incidence and activities of dissimilatory sulfate-reducing bacteria in the human oral cavity. FEMS Microbiol. Lett. 129, 267272 (1995).
  • 6
    Danser, M.M., Gomez, S.M. and Van Der Weijden, G.A. Tongue coating and tongue brushing: a literature review. Int. J. Dent. Hyg. 1, 151158 (2003).
  • 7
    Quirynen, M., Avontroodt, P., Soers, C., Zhao, H., Pauwels, M. and Van Steenberghe, D. Impact of tongue cleansers on microbial load and taste. J. Clin. Periodontal. 31, 506510 (2004).
  • 8
    Pedrazzi, V., Sata, S., De Mattos, M.G., Lara, E.H. and Panzeri, H. Tongue-cleansing methods: a comparative clinical trial employing a toothbrush and a tongue scraper. J. Periodontal. 75, 100910012 (2004).
  • 9
    Farrell, S., Baker, R.A., Somogyi-Mann, M., Witt, J.J. and Gerlach, R.W. Oral malodor reduction by a combination of chemotherapeutical and mechanical treatments. Clin. Oral Investig. 10, 157163 (2006).
  • 10
    Rosenberg, M. Clinical assessment of bad breath: current concepts. J. Am. Dent. Assoc. 127, 475482 (1996).
  • 11
    Rosenberg, M. Diagnosis and treatment of bad breath. Cosmet. Toiletries 111, 8590 (1996).
  • 12
    Wozniak, W.T. The ADA guidelines on oral malodor products. Oral Dis. 11(Suppl. 1), 79 (2005).
  • 13
    Loesche, W.J. The effects of antimicrobial mouthrinses on oral malodor and their status relative of U.S. Food and Drug Administration regulations. Quintessence Int. 30, 311318 (1999).
  • 14
    Tüzün, B., Firatli, S., Tüzün, Y., Firatli, E. and Wolf, R. Oral therapeutics and oral cosmetics. Clin. Dermatol. 19, 449451 (2001).
  • 15
    Loesche, W.J. Microbiology and treatment of haliotosis. Curr. Infect. Dis. Rep. 5, 220226 (2003).
  • 16
    Mitsui, T. (ed.) Oral care cosmetics. In: New Cosmetic Science, pp. 479490. Elsevier, Tokyo (1997).
  • 17
    Pianotti, R., Lachette, S. and Dills, S. Desulfuration of cysteine and methionine by Fusobacterium nucleatum. J. Dent. Res. 65, 913917 (1986).
  • 18
    Yaegaki, K. Periodontal disease and precursor of oral malodor component. J. Dent. Health 39, 733741 (1989).
  • 19
    Perrson, S., Claesson, R. and Carlsson, J. The capacity of subgingical microbiotas to produce volatile sulfur compounds in human serum. Oral Microbiol. Immunol. 4, 169172 (1989).
  • 20
    Persson, S., Edlund, M.B., Claesson, R. and Carlsson, J. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral. Microbiol. Immunol. 5, 195201 (1990).
  • 21
    Claesson, R., Edlund, M.B., Persson, S. and Carlsson, J. Production of volatile sulphur compounds by various Fusobacterim species. Oral Microbiol. Immunol. 5, 137142 (1990).
  • 22
    Mcnamara, T.F., Alexander, J.F. and Lee, M. The role of microorganisms in the production of oral malodor. Oral Surg. Oral Med. Oral Pathol. 34, 4148 (1972).
  • 23
    Goldberg, S., Cardash, H., Browning, H., Sahly, H. and Rosenberg, M. Isolation of Enterobacteriaceae from the mouth and potential association with malodor. J. Dent. Res. 76, 17701775 (1997).
  • 24
    Washio, J., Sata, T., Ikawa, K., Tanda, N., Iwakura, M., Koseki, T. and Takahasi, N. Relationship between hydrogen sulfide-producing bacteria of the tongue coating and oral malodor. Int. Congr. Ser. 1284, 199200 (2005).
  • 25
    Kaizu, T. Analysis of volatile sulphur compounds in mouth air by gas chromatography. J. Jpn. Assoc. Periodontol. 18, 112 (1976).
  • 26
    Yaegaki, K. and Sanada, K. Volatile sulfur compounds in mouth air from clinically healthy participants and patients with periodontal disease. J. Periodontol. Res. 27, 233238 (1992).
  • 27
    Tonzetich, J. Direct gas chromatographic analysis of sulphur compounds in mouth air in man. Arch. Oral Biol. 16, 587597 (1971).
  • 28
    Goldberg, S., Kozlovsky, A. and Gordon, D. Cadavarine as a putative component of oral malodor. J. Dent. Res. 73, 11681172 (1994).
  • 29
    Porter, S.R. and Scully, C. Oral malodor (haliotosis). Br. Med. J. 333, 632635 (2006).
  • 30
    Law, D.B., Berg, M.S. and Fosdick, L.S. Chemical studies in periodontal disease. J. Dent. Res. 22, 373379 (1943).
  • 31
    Kostelc, J.G. Volatiles of exogenous origin from the human oral cavity. J. Chromatogr. 226, 315323 (1981).
  • 32
    Greenman, J., El-Maaytah, M., Duffield, J., et al. Assessing the relationship between concentrations of malodor compounds and odor scores from judges. J. Am. Dent. Assoc. 136, 749757 (2005).
  • 33
    Greenman, J., Duffield, J., Spencer, P., et al. Study on the organoleptic intensity scale for measuring oral malodor. J. Dent. Res. 83, 8185 (2004).
  • 34
    Tonzetich, J. Production and origin of oral malodor: a review of mechanisms and methods of analysis. J. Periodontol. 48, 1320 (1977).
  • 35
    Tangerman, A. Halitosis in medicine: a review. Int. Dent. J. 52, 201206 (2002).
  • 36
    Murata, T., Yamagata, T., Iida, T., Miyazaki, H. and Yaegaki, K. Classification and examination of halitosis. Int. Dent. J. 52, 181186 (2002).
  • 37
    Awano, S., Koshimune, S., Kurihara, E., et al. The assessment of methyl mercaptan, an important clinical marker for the diagnosis or oral malodor. J. Dent. 32, 555559 (2004).
  • 38
    Hori, H., Takabayashi, K., Orvis, L., Carson, D.A. and Nobori, T. Gene cloning and characterization of Pseudomonas putidal-methionine-α-deamino-γ-mercaptomethane-lyase. Cancer Res. 56, 21162122 (1996).
  • 39
    Inoue, H., Imaki, K., Sugimoto, M., Esaki, N., Soda, K. and Tanaka, H. Structural analysis of l-methionine γ-lyase gene from Pseudomonas putida. J. Biochem. 117, 11201125 (1995).
  • 40
    Lockwood, B.C. and Cooms, G.H. Purification and characterization of methionine γ-lyase from Trichmonas vaginalis. Biochem. J. 279, 675682 (1991).
  • 41
    Kreis, W. and Hession, C. Isolation and purification of l-methionine-α-deamino-γ-mercaptomethane-lyase (l-methioninase) from Clostridium sporogenes. Cancer Res. 33, 18621865 (1973).
  • 42
    Tábi, T., Lohinai, Z., Pálfi, M., Levine, M. and Szökö, É. CE-LIF determination of salivary cadaverine and lysine concentration ratio as an indicator of lysine decarboxylase enzyme activity. Anal. Bioanal. Chem. 391, 647651 (2008).
  • 43
    Li, J., Helmerhorst, E.J., Leone, C.W., et al. Identification of early microbial colonizers in human dental biofilm. J. Appl. Microbiol. 97, 13111318 (2004).
  • 44
    Levine, M., Progulske-Fox, A., Denslow, N.D., et al. Identification of lysine decarboxylase as a mammalian cell growth inhibitor in Eikenella corrodens: possible role in periodontal disease. Microb. Pathog. 30, 179192 (2001).
  • 45
    Philips, M., Cataneo, R.N., Greenberg, J., Munawar, W.I., Nachnani, S. and Samtani, S. Pilot study of a breath test for volatile organic compounds associated with oral malodor: evidence for the role of oxidative stress. Oral Dis. 11(Suppl. 1), 3234 (2005).
  • 46
    Therond, P., Bonnefont-Rousselot, D., Davit-Spraul, A., Conti, M. and Legrand, A. Biomarkers of oxidative stress: an analytical approach. Curr. Opin. Clin. Nutr. Metab. Care 3, 373384 (2000).
  • 47
    Kneepkens, C.M., Ferreira, C., Lepage, G. and Roy, C.C. The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. Clin. Invest. Med. 15, 163186 (1992).
  • 48
    Calil, C.M. and Marcondes, F.K. Influence of anxiety on the production of oral volatile sulfur compounds. Life Sci. 79, 660664 (2006).
  • 49
    Miyazaki, H., Sakao, S., Katoh, Y. and Takehara, T. Correlation between volatile sulphur compounds and certain oral health measurements in the general population. J. Periodontol. 66, 679684 (1995).
  • 50
    Sopapornamorn, P., Ueno, M., Shinada, K., Yanagishita, M. and Kawaguchi, Y. Relationship between total salivary protein content and volatile sulfur compounds levels in malodor patients. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103, 655660 (2007).
  • 51
    Willis, C.L., Gibson, G.R., Holt, J. and Alison, C. Negative correlation between oral malodour and numbers and activities of sulphate-reducing bacteria in the human mouth. Arch. Oral Biol. 44, 665670 (1999).
  • 52
    Wang, C.K., Chen, S.L. and Wu, M.G. Inhibitory effect of betel quid on the volatility of methyl mercaptan. J. Agric. Food Chem. 49, 19791983 (2001).
  • 53
    Ramji, N., Ramji, N., Iyer, R. and Chandrasekaran, S. Phenolic antibacterials from Piper betel in the prevention of haliotosis. J. Ethnopharmacol. 83, 149152 (2002).
  • 54
    Zhou, J.H. Composition and method for inhibiting oral bacteria. U.S. patent 6 319 523 B1. Playtex Products Inc., Cincinnati (2001).
  • 55
    Garlich, J.R., Masterson, T.T. and Frank, R.K. Phytate antimicrobial compounds in oral care products. U.S. patent 5 300 289. Dow Chemical Co., Michigan (1994).
  • 56
    Sterer, N., Nuas, S., Mizrahi, B., Goldenberg, C., Weiss, E.I., Domb, A. and Davidi, M.P. Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation. J. Dent. 36, 535539 (2008).
  • 57
    Xiong, H., Li, Y., Slavik, M.F. and Walker, J.T. Spraying chicken skin with selected chemicals to reduce attached Salmonella typhimurium. J. Food Prot. 61, 272275 (1998).
  • 58
    Rölla, G. Oral composition for inhibiting oral malodor. U.S. patent 6 344 184 B1. Orix As, Bekkestua (2002).
  • 59
    Yaegaki, K. and Sanada, K. Effects of a two-phase oil-water mouthwash on halitosis. Clin. Prev. Dent. 14, 59 (1992).
  • 60
    Garlich, J.R., Frank, R.K., Kiefer, G.E. and Wilson, D.A. Oral compositions for inhibiting plaque formation. U.S. patent 5 320 829. Dow Chemical Co., Michigan (1994).
  • 61
    Tashjian, A. and Mills, S. Hygiene mouthspray composition. U.S. patent 6 579 513 B1. Playtex Products Inc., Cincinnati (2003).
  • 62
    Adamy, S.T. Oral composition containing cetylpyridinium chloride and guar hydroxypyltrimonium chloride and method of using the same. U.S. patent 6 355 229 B1. Church & Dwight Co. Inc., NJ, U.S.A. (2002).
  • 63
    Morgan, A.M., Szeles, L.H., Williams, M., et al. Enzyme containing oral composition having enhanced stability. U.S. patent 0 156 796 A1. Colgate-Palmolive Co., New Jersey (2004).
  • 64
    Garlich, J.R., Masterson, T.T., Simon, J. and Hegde, V.B. Oral compositions for suppressing mouth odors. U.S. patent 5 286 479. Dow Chemical Co., Michigan (1994).
  • 65
    Nelson, D.G.A. and Ortega, A.V. Stable zinc/citrate/cpc oral rinse formulations. U.S. patent 5 948 390. Pfizer Inc., New York (1999).
  • 66
    Witt, J.J., Wimalasena, R.L., Goulbourne, E.A. and Doyle, M.J. Oral care compositions comprising chlorite and methods. U.S. patent 6 350 438 B1. Procter & Gamble Co., Cincinnati (2002).
  • 67
    Dever, J.G. Oral hygiene in mentally handicapped children. A clinical trial using a chlorhexidine sprays. Aust. Dent. J. 24, 301305 (1979).
  • 68
    Rosenberg, M., Gelernter, I., Barki, M. and Bar-Ness, R. Daylong reduction of oral malodor by a two-phase oil-water mouthrinse as compared to chlorhexidine and placebo rinses. J. Periotentol. 63, 3943 (1992).
  • 69
    Bosy, A., Kularni, G.V., Rosenberg, M. and McCulloch, C.A. Relationship of oral malodor to periodontitis: evidence of independence in discrete subpopulations. J. Periodontol. 65, 3746 (1994).
  • 70
    Carvalho, M.D., Tabchoury, C.M., Cury, J.A., Toledo, S. and Nogueira-Filho, G.R. Impact of mouthrinses on morning bad breath in healthy subjects. J. Clin. Periodontol. 31, 8590 (2004).
  • 71
    Adams, D. and Addy, M. Mouth rinses. Adv. Dent. Res. 8, 291301 (1994).
  • 72
    Andy, M. and Moran, J.M. Clinical indications for the use of chemical adjuncts to plaque control: chlorhexidine formulations. Periodontology 15, 5254 (1997).
  • 73
    Marinone, M.G. and Savoldi, E. Chlorhexidine and taste. Influence of mouthwashes concentration and of rinsing time. Minerva Stomatol. 49, 221226 (2000).
  • 74
    Young, A., Jonski, G. and Rölla, G. Inhibition of orally produced volatile sulphur compounds by zinc, chlorhexdine or cetylpyridinium chloride – effect of concentration. Eur. J. Oral Sci. 111, 400404 (2003).
  • 75
    Krespi, Y.P., Shrime, M.G. and Kacker, A. The relationship between oral malodor and volatile sulfur compound-producing bacteria. J. Otolaryngol. Head Neck Surg. 135, 671676 (2006).
  • 76
    Lynch, E., Sheerin, A., Claxson, A.W., et al. Multicomponent spectroscopic investigations of salivary antioxidant consumption by an oral rinse preparation containing the stable free radical species chlorine dioxide (ClO2). Free Radic. Res. 26, 209234 (1997).
  • 77
    Sasson, J.A. and Panicucci, R. Antimicrobial oral composition and method of use. U.S. patent 6 280 775 B1. Miami (2001).
  • 78
    Frascella, J., Gilbert, R.D., Fernandez, P. and Hendler, J. Efficacy of a chloride dioxide containing mouthrinse in oral malodor. Compend. Contin. Educ. Dent. 21, 241256 (2000).
  • 79
    Kleinberg, I. and Codipilly, D.M. Cysteine challenge testing: a powerful tool for examining oral malodor processing and treatments in vivo. Int. Dent. J. 52(Suppl. 3), 221228 (2002).
  • 80
    Ratcliff, P. Oral health preparation and method. U.S. patent 5 348 734. Micropure Inc., Scottsdale (1994).
  • 81
    Witt, J.J., Wimalasena, R.L., Wong, A.L. and Goulbourne, E.A. Oral care compositions comprising chlorite and methods. U.S. patent 6 077 502. Procter & Gamble Co., Ohio (2000).
  • 82
    Witt, J.J., Wimalasena, R.L. and Wong, A.L. Oral care compositions comprising chlorite and methods. U.S. patent 6 132 702. Procter & Gamble Co., Ohio (2000).
  • 83
    Witt, J.J., Wimalasena, R.L., Wong, A.L. and Goulbourne, E.A. Oral care compositions comprising chlorite and methods. U.S. patent 6 264 924 B1. Procter & Gamble Co., Ohio (2001).
  • 84
    Christopfel, W.C. Method or reducing oral malodor. U.S. patent 6 325 997 B1. Oxyfresh Worldwide Inc., Washington (2001).
  • 85
    Fiessinger, F., Richard, Y., Montiel, A. and Musquere, P. Advantages and disadvantages of chemical oxidation and disinfection by ozone and chlorine dioxide. Sci. Total Environ. 18, 245261 (1981).
  • 86
    Greenstein, R.B., Goldberg, S., Marku-Cohen, S., Sterer, N. and Rosenberg, M. Reduction of oral malodor by oxidizing lozenges. J. Periodontol. 68, 11761181 (1997).
  • 87
    Edris, A.E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytother. Res. 21, 308323 (2007).
  • 88
    Imai, H., Osawa, K., Uasuda, H., Hamashima, H., Arai, T. and Sasatsu, M. Inhibition by the essential oils of peppermint and spearmint of the growth of pathogenic bacteria. Microbiology 106, 3139 (2001).
  • 89
    Olshan, A.M., Kohut, B.E., Vincent, J.W., et al. Clinical effectiveness of essential oil-containing dentifrices in controlling oral malodor. Am. J. Dent. 13, 18C22C (2000).
  • 90
    Charles, C., Mostler, K., Bartels, L. and Mankodi, S. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6 months clinical trial. J. Clin. Periodontol. 31, 878884 (2004).
  • 91
    Pilch, S., Williams, M. and Vazquez, J. Oral care malodor composition. U.S. patent 0 134 023 A1. Colgate-Palmolive Co., New Jersey (2006).
  • 92
    Harper, D.S., Parikh, R.M., Alli, D. and Talwar, A. Antiseptic dentifrice. U.S. patent 5 942 211. Warner-Lambert Co., New Jersey (1999).
  • 93
    Liu, X., Williams, M., Subramanyam, R. and Hughes, J. Oral composition for reducing mouth odors. U.S. patent 6 379 652 B1. Colgate-Palmolive Co., New Jersey (2002).
  • 94
    Pan, P., Finnegan, M., Soshinsky, A., Arvanitis, G. and Berardini, M. Oral care compositions comprising tropolone compounds and essential oils and methods of using the same. U.S. patent 6 689 342 B1. Warner-Lambert Co., New Jersey (2004).
  • 95
    Stier, R.E. Oral care compositions comprising diglycerol. U.S. patent 6 723 304 B2. Noville Inc., New Jersey (2004).
  • 96
    Meyers, A.J., Lutrario, C.A., Elliott, M. and Gallagher, L.A. Breath freshening lipstick. U.S. patent 6 383 475 B1. FD Management Inc., Delaware (2002).
  • 97
    Saurez, F.L., Furne, J.K., Springfield, J. and Levitt, M.D. Morning breath odor: influence of treatments of analysis. J. Periodontol. 48, 1320 (2000).
  • 98
    Grigor, J. and Roberts, A.J. Reduction in the levels of oral malodor precursors by hydrogen peroxide: in vitro and in vivo assessments. J. Clin. Dent. 3, 111115 (1992).
  • 99
    Rösing, C.K., Jonski, G. and Rölla, G. Comparative analysis of some mouthrinses on the production of volatile sulfur-containing compounds. Acta Odontol. Scand. 60, 1012 (2002).
  • 100
    Brunette, D.M. Effects of baking soda containing dentifrices on oral malodor. Compend. Contin. Educ. Dent. Suppl. 18, S22S32 (1997).
  • 101
    Brading, M.G., Cromwell, V.J., Green, A.K., DeBrabander, S. and Beasley, T. The role of triclosan in dentifrice formulations with particular reference to a new 0.3% triclosan calcium carbonate based system. Int. Dent. J. 54, 291298 (2004).
  • 102
    Young, A., Jonski, G. and Rölla, G. A study of triclosan and its solubilizers as inhibitors of oral malodor. J. Clin. Periodontol. 29, 10781081 (2002).
  • 103
    Hao, Z., Parker, B. and Knapp, M. In vitro stability of triclosan in dentifrice under simulated use condition. Int. J. Cosmet. Sci. 29, 353359 (2007).
  • 104
    Nogueira-Filho, G.R., Duarte, P.M., Toledo, S., Tabchoury, C.P. and Cury, J.A. Effect of triclosan dentifrices on mouth volatile sulphur compounds and dental plaque trypsin-like activity during experimental gingivitis. J. Clin. Periodontol. 29, 10591064 (2002).
  • 105
    Szeles, L.H., Liu, X., Williams, M. and Masters, J.G. Antibacterial dentifrice exhibiting antiplaque and breath freshening properties. U.S. patent 0 211 054 A1. Colgate-Palmolive Co., New Jersey (2003).
  • 106
    Hu, D., Zhang, Y.P., Petrone, M., Volpe, A.R., DeVizio, W. and Giniger, M. Clinical effectiveness of a triclosan/copolymer/sodium fluoride dentifrice in controlling oral malodor: a 3-week clinical trial. Oral Dis. Suppl. 11, 5153 (2005).
  • 107
    Niles, H.P., Hunter, C., Vazquez, J., Williams, M.I. and Cummins, D. The clinical comparison of a triclosan/copolymer/fluoride dentifrices vs a breath-freshening dentifrice in reducing breath odor overnight: a crossover study. Oral Dis. Suppl. 11, 5456 (2005).
  • 108
    Pilch, S., Williams, M.I. and Cummnins, D. Effect of a triclosan/PVM/MA copolymer/fluoride dentifrice on volatile sulfur compounds in vitro. Oral Dis. Suppl. 11, 5760 (2005).
  • 109
    Vazquez, J., Pilch, S., Williams, M.I. and Cummins, D. Clinical efficacy of a triclosan/copolymer/NaF dentifrice and a commercially available breath-freshening dentifrice on hydrogen sulfide-forming bacteria. Oral Dis. Suppl. 11, 6466 (2005).
  • 110
    Young, A., Jonski, G., Rölla, G. and Waler, S.M. Effects of metal salts on the oral production of volatile sulfur-containing compounds (VSC). J. Clin. Periodontol. 28, 776781 (2001).
  • 111
    Schmidt, N.F. and Tarbet, W.J. The effect of oral rinses on organoleptic mouth odor ratings and levels of volatile sulfur compounds. Oral. Surg. Med. Oral Pathol. 45, 876883 (1978).
  • 112
    Schiraldi, M.T. and Denton, R.K. Stable oral composition of zinc. U.S. patent 4 992 259. Johnson & Johnson Consumer Products Inc., New Jersey (1991).
  • 113
    Van Steenberghe, D., Avontroodt, P., Peeters, W., Pauwels, M., Coucke, W., Lijnen, A. and Quirynen, M. Effect of different mouthrinses on morning breath. J. Periodontol. 72, 117831191 (2001).
  • 114
    Subramanyam, R., Williams, M., Gebreselassie, P., Liu, X., Zaccagnino, A. and Masters, J.G. Dual component dentifrice for reducing mouth odors. U.S. patent 6 375 933 B1. Colgate-Palmolive Co., New Jersey (2002).
  • 115
    Winkel, E.G., Roldán, S., Van Winkelhoff, A.J., Herrara, D. and Sanz, M. Clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis: a dual-center, double-blind, placebo-controlled study. J. Clin. Periodontol. 30, 300306 (2003).
  • 116
    Young, A., Jonski, G. and Rölla, G. Combined effect of zinc ions and cationic antibacterial agents on intraoral volatile sulphur compounds (VSC). Int. Dent. J. 53, 237242 (2003).
  • 117
    Roldán, S., Winkel, E.G., Herrara, D., Sanz, M. and Van Winkelhoff, A.J. The effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc lactate on the microflora of oral halitosis patients: a dual-center, double-blind, placebo-controlled study. J. Clin. Periodontol. 30, 427434 (2003).
  • 118
    Brunette, D.M., Proskin, H.M. and Nelson, B.K. The effects of dentifrice systems on oral malodor. J. Clin. Dent. 9, 7682 (1998).
  • 119
    Wåler, S.M. The effect of zinc-containing chewing gum on volatile sulfur-containing compounds in the oral cavity. Acta Odontol. Scand. 55, 198200 (1997).
  • 120
    Phillips, D.M. Composition with activated carbon in oral treatment. U.S. patent 0 286 821 A1. Merchant & Gould Pc., Minnesota (2007).
  • 121
    Pan, P., Finnegan, M., Soushinsky, A., Arvanitis, G. and Berardini, M. Substituted tropolone compounds, oral care compositions containing the same and methods of using the same. U.S. patent 6 787 675 B2. Warner-Lambert Co., New Jersey (2004).
  • 122
    Xu, G., Reci, M., Blackwell, B.L., Robinson, R.S., Viscio, D.B. and Curtis, J.P. Breath freshening film. U.S. patent 6 419 903 B1. Colgate-Palmolive Co., New York (2002).
  • 123
    Szeles, L.H., Mohseni, S., Xu, G., Williams, M., Viscio, D.B. and Masters, J.G. Enzyme enhanced breath freshening film. U.S. patent 0 018 156 A1. Colgate-Palmolive Co., New Jersey (2004).
  • 124
    Glandorf, W.M., Bacca, L.A., White, D.J. and Busscher, H.J. Stannous oral compositions. U.S. patent 6 55 094 B1. Procter & Gamble Co., Ohio (2003).
  • 125
    Kim, J.J. Mouthwash composition for the prevention of dental diseases. U.S. patent 0 154 410 A1. Pennsylvania (2007).